semaglutide healthy & Mental Health 💙 Real results, real transformation

This is most likely due to the discontinuation of the previous GLP-1 RA therapy and other oral glucose-lowering medications (DPP-4is, glinides and sulfonylureas) at randomisation, combined with the gradual up-titration of IcoSema or escalation of semaglutide from a lower initiating dose than participants were receiving before the trial

By taking these steps, you can navigate the side effects of semaglutide more comfortably, ensuring a smoother journey towards your health goals

Purpose-built for physicians More than half of adults with obesity stop using Wegovy within 1 year Key takeaways: Of adults with obesity who initiated semaglutide in Denmark, 52% discontinued use within 1 year

Conclusion Understanding GLP-1 side effects requires more than watching the number on a scale